CLINICAL_TRIALS
trial_result
· 2012-08-08
Clinical Trial Update: Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III) [Phase 4]
Summary
Phase 4 clinical trial LONG-DES-III evaluating percutaneous treatment of long native coronary lesions with a drug-eluting stent has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED